As of 2026, yes through exactly one vetted program
These findings were confirmed by various molecular investigations, such as IHC, ELISA, and PCR
Medicaid spending on GLP-1s for all conditions increased from $597.3 million for about 755,000 prescriptions in 2019, to $3.9 billion for 3.8 million prescriptions in 2023, according to KFF
To more definitively identify complexes containing both ASPL and VCP, we immunoprecipitated endogenous ASPL from the 3-FLAGASPL cells using anti-FLAG antibody
People do now question just because something came through the FDA doesn't mean it's safe
GHK is a copper-binding peptide that occurs naturally in the human body